OPC Pharmaceutical JSC (HOSE:OPC)
Vietnam · Delayed Price · Currency is VND 20,950
-550 (-2.56%)
At close: Jul 24, 2026
OPC Pharmaceutical JSC Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,128,779 | 1,122,987 | 968,576 | 1,004,887 | 1,171,614 | 1,123,728 |
Revenue Growth | 17.84% | 15.94% | -3.61% | -14.23% | 4.26% | 16.38% |
Gross Profit Gross Profit Growth | 526,482 | 531,534 | 446,118 | 478,431 | 533,708 | 480,229 |
Operating Income Operating Income Growth | 126,222 | 132,289 | 134,434 | 146,120 | 178,636 | 166,713 |
Net Income Net Income Growth | 95,364 | 98,499 | 94,408 | 103,557 | 128,118 | 112,961 |
Earnings Per Share EPS Growth | 1272.55 | 1314.37 | 1259.79 | 1381.88 | 1709.40 | 1507.36 |
EPS Growth | 6.73% | 4.33% | -8.83% | -19.16% | 13.40% | 19.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 245,665 | 319,169 | 247,287 | 321,361 | 315,205 | 218,148 |
Total Debt Total Debt Growth | - | - | - | - | - | 71,337 |
Net Cash (Debt) Net Cash Growth | 245,665 | 319,169 | 247,287 | 321,361 | 315,205 | 146,811 |
Net Cash Growth | -3.50% | 29.07% | -23.05% | 1.95% | 114.70% | 1007.84% |
Net Cash Per Share Net Cash Per Share Growth | 3278.18 | 4259.02 | 3299.82 | 4288.27 | 4206.13 | 1959.07 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -12,217 | 59,928 | 23,725 | 255,359 | 36,088 | 190,721 |
Capital Expenditures CapEx Growth | -27,257 | -18,253 | -11,578 | -12,042 | -7,399 | -8,912 |
Free Cash Flow Free Cash Flow Growth | -39,475 | 41,675 | 12,147 | 243,317 | 28,688 | 181,809 |
Free Cash Flow Growth | - | 243.09% | -95.01% | 748.14% | -84.22% | 94.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.64% | 47.33% | 46.06% | 47.61% | 45.55% | 42.73% |
Operating Margin | 11.18% | 11.78% | 13.88% | 14.54% | 15.25% | 14.84% |
Pretax Margin | 12.65% | 13.18% | 14.16% | 15.46% | 15.36% | 14.17% |
Profit Margin | 8.45% | 8.77% | 9.75% | 10.30% | 10.94% | 10.05% |
FCF Margin | -3.50% | 3.71% | 1.25% | 24.21% | 2.45% | 16.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 683.761 | 683.761 | - | 1282.051 | 1282.051 |
Dividend Per Share Growth | 0% | - | - | 0% | - |
Dividend Yield | 3.18% | 3.45% | - | 6.88% | 6.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.46 | 15.61 | 16.96 | 14.84 | 13.75 | 13.46 |
P/FCF Ratio | - | 36.89 | 131.82 | 6.32 | 61.40 | 8.36 |
PS Ratio | 1.39 | 1.37 | 1.65 | 1.53 | 1.50 | 1.35 |